These studies largely confirmed the presence of known stem cell markers such as Yamanaka factors, CD133, CD44, CD24, CD106, Sca-1, etc. in the presumptive kidney stem/progenitor cells, which supports using some of these markers for identifying or validating the presence of TICs in RCC. This evidence concerns the gene PROM1 and renal cell carcinoma.